跳至主要内容
临床试验/NCT04642313
NCT04642313Unknown不适用

Comparison of Magnesium Versus Potassium and Their Combined Effect on Insomnia, Sleep Hormones, Insulin Resistance and Quality of Life Among Patients With Diabetes Mellitus".

University of Lahore4 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2020年10月26日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
320
试验地点
4
主要终点
Effects of magnesium and/ or potassium supplementation on insomnia severity patients with diabetes mellitus

研究概览

简要总结

Insomnia is increasing alarmingly among the population. Micronutrient fluctuations have been shown to effect insulin secretion, period of circadian cycle and quality of sleep in all ages. This study is aimed to identify the impact of magnesium and potassium supplementation on insomnia severity and duration, and insulin resistance, quality of life, sleep hormones, serum magnesium and potassium levels. Moreover, the study will help to find out the link between insomnia and micronutrients among patients of diabetes mellitus so that the burden of the disease in the society could be reduced.

详细描述

Sleep is the essential component to maintain good health of an individual. Insomnia is defined as a condition that affects an individual by inability to get sufficient quality sleep or problem in maintaining sleep that is important for healthy functioning, performance and well being. Insomnia can exist in healthy individual or comorbidly with other medical diseases. Latest researches indicate that intolerance of glucose in the body, resistance to insulin hormone, decreased acute response of insulin to glucose and increased chances of having type 2 diabetes are reasons for reduced or interrupted sleep. Several electrolytes and minerals influence the sleep cycle. Magnesium is important in regulation of central nervous system excitability, through ion channel conductivity. Magnesium is a muscle relaxant and inducer of the deeper sleep. Hypomagnesemia is a common feature in patients with type 2 diabetes. Although diabetes can induce hypomagnesemia, magnesium deficiency has also been proposed as a risk factor for type 2 diabetes. Magnesium supplementation improves sleep efficiency, sleep time and sleep onset latency, early morning awakening, and insomnia objective measures such as the concentration of serum renin, melatonin, and serum cortisol, in older adults. High ambient potassium levels have been shown to shorten the period of circadian rhythms in a variety of organisms. Little is known about the effects of dietary mineral nutrients on human sleep quality. Potassium depletion has been shown to cause glucose intolerance, which is associated with impaired insulin secretion . Recently, there has been growing evidence from both animal and human studies indicating that high sodium and low potassium intakes are associated with a high risk of insulin resistance or diabetes.

The Study is aimed to:

  1. To compare the effect of magnesium and/ or potassium on insomnia patients with diabetes mellitus

  2. To compare the gender and age based response to magnesium and/ or potassium on insomnia patients with diabetes mellitus

  3. To compare the effect of magnesium and/ or potassium on insulin resistance among insomnia patients with diabetes mellitus

  4. To compare the effect of magnesium and/ or potassium on sleep hormones among insomnia patients with diabetes mellitus

  5. To compare the effect of magnesium and/ or potassium on serum electrolytes (Mg, K) among insomnia patients with diabetes mellitus

  6. To compare the effect of magnesium and/ or potassium on quality of life (QOL) among insomnia patients with diabetes mellitus MATERIAL AND METHODS Study Design: Randomized Controlled Trial (single blind) Settings: Study will be conducted at

  7. Akhuwat Health Services, Lahore Duration of Study: 18 months (after the approval of synopsis) Sample Size: is 280 and with expected 20% drop out: 320 Sampling Technique: Non probability purposive sampling

Inclusion Criteria:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

It will be single blind study, Participants will not be aware of the treatment group, they are receiving

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Patients of diabetes mellitus with insomnia
  • Adult diabetic patients aged between 19 to 65 years
  • Patients of both genders
  • Diabetic patients of insomnia with or without anti-diabetic drugs
  • Diabetic patients of insomnia with or without Hypomagnesaemia
  • Diabetic patients of insomnia with or without Hypokalemia

排除标准

  • Individuals with the following conditions will not be included as participants, patients of diabetes mellitus with insomnia with
  • Psychiatry reasons
  • Any hormonal treatment
  • CVD/ Other metabolic co-morbidities
  • History of acute liver injury (e.g., hepatitis) or severe cirrhosis
  • Renal diseases (renal stones, renal failure, dialysis)
  • Diabetic nephropathy
  • Pregnancy
  • Breast-feeding
  • Drug induced insomnia
  • Sleep disorders
  • Sleep-related movement disorders (restless leg syndrome)
  • Sleep-related respiratory disorders (sleep apnea)
  • Alcohol consumption
  • Cardiac respiratory disorders
  • Painful condition (apathy)
  • History of chronic liver disease
  • History of CKD
  • Participation in a study of an investigational medication or nutritional supplements/ medication within the past 90 days

结局指标

主要结局

Effects of magnesium and/ or potassium supplementation on insomnia severity patients with diabetes mellitus

时间窗: 60 days

Insomnia Severity Index (ISI) will be used to assess and categorize the insomnia among patients with diabetes mellitus, before and after the intervention

Effects of magnesium and/ or potassium on sleep hormones (melatonin, cortisol) among insomniac patients with diabetes mellitus.

时间窗: 60 days

Sleep hormones (melatonin, cortisol) will be measured before and after the intervention, through ELISA technique, among insomniac patients with diabetes mellitus.

Effects of magnesium and/ or potassium on insulin resistance among insomnia patients with diabetes mellitus

时间窗: 60 days

Homeostatic model assessment for insulin resistance (HOMA-IR) will be used to measure the insulin resistance before and after the Mg, K supplementation among insomniac patients with diabetes mellitus. Insulin will be measured through ELISA technique.

Effect of magnesium and/ or potassium on serum electrolytes (Mg, K) among insomnia patients with diabetes mellitus

时间窗: 60 days

Serum magnesium and/ potassium (in blood) will be measured through chemistry analyzer, before and after the Mg, K supplementation among insomniac patients with diabetes mellitus

次要结局

  • Effect of magnesium and/ or potassium on quality of life (QOL) among insomnia patients with diabetes mellitus(60 days)
  • Gender and age based response to magnesium and/ or potassium on insomnia patients with diabetes mellitus(60 days)

研究者

发起方
University of Lahore
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sidra Khalid

PhD Scholar

University of Lahore

研究点 (4)

Loading locations...

相似试验